Hereditary tumor syndromes and gliomas

45Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Several congenital syndromes caused by germline mutations in tumor suppressor genes predispose to the development of glial tumors. In the last few decades our knowledge about the molecular functions of these genes and the pathogenesis of hereditary tumor syndromes has greatly increased. The most common syndromes are the neu-rofibromatoses (type 1 and type 2) and the tuberous scleroses complex. There are interesting overlaps in the molecular pathogen-esis. Deregulation of Ras or downstream Ras pathways including MEK/ERK and AKT/ mTOR plays an important role in these three syndromes. Other rare syndromes include Li-Fraumeni, melanoma-astrocytoma, and Turcot syndrome involving cell cycle regulators and DNA repair genes. The genes and pathways involved in the pathogenesis of these syndromes also play an important role in the development of sporadic tumors. Therefore research on hereditary syndromes contributes substantially to our understanding of tumor formation. © 2009 Springer Berlin Heidelberg.

Cite

CITATION STYLE

APA

Reuss, D., & Von Deimling, A. (2009). Hereditary tumor syndromes and gliomas. Recent Results in Cancer Research. https://doi.org/10.1007/978-3-540-31206-2_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free